Literature DB >> 21865188

Validation of the Infectious Diseases Society of America/American Thoratic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care.

James D Chalmers1, Joanne K Taylor, Pallavi Mandal, Gourab Choudhury, Aran Singanayagam, Ahsan R Akram, Adam T Hill.   

Abstract

BACKGROUND: The 2007 Infectious Disease Society of America/American Thoracic Society (IDSA/ATS) guidelines for community-acquired pneumonia (CAP) recommended new criteria to guide admission to the intensive care unit (ICU) for patients with this condition. Although the major criteria (requirement for mechanical ventilation or septic shock requiring vasopressor support) are well established, the value of the minor criteria alone have not been fully validated.
METHODS: We performed a prospective observational study of consecutive adult patients with CAP admitted to NHS Lothian (Scotland, United Kingdom). Patients meeting the IDSA/ATS major criteria on admission were excluded, along with patients not suitable for ICU care owing to advanced directives or major comorbid illnesses. Performance characteristics for the IDSA/ATS minor criteria were calculated and compared with those for alternative scoring systems identified in the literature. Two definitions of severe CAP were used as primary end points: ICU admission, and subsequent requirement for mechanical ventilation or vasopressor support (MV/VS); 30-day mortality was a secondary outcome.
RESULTS: The study included 1062 patients with CAP potentially eligible for ICU admission. Each of the 9 minor criteria was associated with increased risk of MV/VS and 30-day mortality in univariate analysis. Two hundred seven patients had ≥ 3 minor criteria (19.5%). The IDSA/ATS 2007 criteria had an area under the receiver operating characteristic curve of 0.85 (0.82-0.88) for prediction of MV/VS, 0.85 (0.82-0.88) for prediction of ICU admission, and 0.78 (0.74-0.82) for prediction of 30-day mortality. The IDSA/ATS 2007 criteria were at least equivalent to more established scoring systems for prediction of MV/VS and ICU admission and equivalent to alternative scoring systems for predicting 30-day mortality in this patient population.
CONCLUSIONS: In a population of patients with CAP without contraindications to ICU care, the IDSA/ATS minor criteria predict subsequent requirement for MV/VS, ICU admission, and 30-day mortality.

Entities:  

Mesh:

Year:  2011        PMID: 21865188     DOI: 10.1093/cid/cir463

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  29 in total

1.  In-Hospital Deaths Among Adults With Community-Acquired Pneumonia.

Authors:  Grant W Waterer; Wesley H Self; D Mark Courtney; Carlos G Grijalva; Robert A Balk; Timothy D Girard; Sherene S Fakhran; Christopher Trabue; Paul McNabb; Evan J Anderson; Derek J Williams; Anna M Bramley; Seema Jain; Kathryn M Edwards; Richard G Wunderink
Journal:  Chest       Date:  2018-05-30       Impact factor: 9.410

2.  A new prediction model for assessing the clinical outcomes of ICU patients with community-acquired pneumonia: a decision tree analysis.

Authors:  Shufang Zhang; Kai Zhang; Yang Yu; Baoping Tian; Wei Cui; Gensheng Zhang
Journal:  Ann Med       Date:  2019-03-23       Impact factor: 4.709

3.  Hospital admission decision for patients with community-acquired pneumonia.

Authors:  Stefano Aliberti; Paola Faverio; Francesco Blasi
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

4.  Why do nonsurvivors from community-acquired pneumonia not receive ventilatory support?

Authors:  Torsten T Bauer; Tobias Welte; Richard Strauss; Helge Bischoff; Klaus Richter; Santiago Ewig
Journal:  Lung       Date:  2013-05-05       Impact factor: 2.584

Review 5.  [Risk scores for community acquired pneumonia in elderly and geriatric patients].

Authors:  M A Pflug; T Wesemann; H J Heppner; U Thiem
Journal:  Z Gerontol Geriatr       Date:  2015-05-09       Impact factor: 1.281

6.  Is N-terminal pro-B-type natriuretic peptide ready for 'prime time' in severe pneumonia?

Authors:  Juan Felipe Fernandez; Marcos I Restrepo
Journal:  Respirology       Date:  2013-08       Impact factor: 6.424

7.  Alcohol abuse and smoking alter inflammatory mediator production by pulmonary and systemic immune cells.

Authors:  Jeanette Gaydos; Alicia McNally; Ruixin Guo; R William Vandivier; Philip L Simonian; Ellen L Burnham
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-08       Impact factor: 5.464

8.  Improving the 2007 Infectious Disease Society of America/American Thoracic Society severe community-acquired pneumonia criteria to predict intensive care unit admission.

Authors:  Oriol Sibila; G Umberto Meduri; Eric M Mortensen; Antonio Anzueto; Elena Laserna; Juan F Fernandez; Ali El-Sohl; Marcos I Restrepo
Journal:  J Crit Care       Date:  2012-12-21       Impact factor: 3.425

9.  Validation of the Pediatric Infectious Diseases Society-Infectious Diseases Society of America Severity Criteria in Children With Community-Acquired Pneumonia.

Authors:  Todd A Florin; Cole Brokamp; Rachel Mantyla; Bradley DePaoli; Richard Ruddy; Samir S Shah; Lilliam Ambroggio
Journal:  Clin Infect Dis       Date:  2018-06-18       Impact factor: 9.079

10.  Efficacy of Omadacycline Versus Moxifloxacin in the Treatment of Community-Acquired Bacterial Pneumonia by Disease Severity: Results From the OPTIC Study.

Authors:  Julio Ramirez; Daniel H Deck; Paul B Eckburg; Marla Curran; Anita F Das; Courtney Kirsch; Amy Manley; Evan Tzanis; Paul C McGovern
Journal:  Open Forum Infect Dis       Date:  2021-06-18       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.